Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer
Pathologie Biologie · 2013-12 · 61 (6) · 273-276
DOI: 10.1016/j.patbio.2013.05.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathologie Biologie, 2013-12. Verfasst von N Marchoudi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de génétique et biologie moléculaire, faculté des sciences Ben'Msik-Bd Driss Elharti, BP 79, 55, Sidi Othman, Casablanca, Morocco; Départ…. Hauptthemen laut MEDLINE: Mutation. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Targeted therapies have an increasing importance in digestive oncology. To our knowledge, we are the first to report the distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer (CRC) in order to introduce targeted therapy in the arsenal of therapeutic modalities for management of this cancer in Morocco. In this study, 92 samples obtained from patients with CRC were tested for the presence of the nine most common mutations in the KRAS gene and BRAF gene. Among the tested patients, 76.09% of patients had wt-KRAS genotype and 23.91% were KRAS mutants and the majority of mutations would result in an amino acid substitution of glycine by aspartic acid (68.2%) The predominant mutations are G>A transitions and G>T transversions. Around 5% (5.43%) of the tested patients bore the V600E mutation in BRAF gene. Only one patient showing to have the V600E mutation in BRAF was also mutated-KRAS. Summing up the results about the KRAS and the BRAF mutation carriers from our study, the portion of potentially non responsive patients for the anti-EGFR treatment is 28.26%.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratoire de génétique et biologie moléculaire, faculté des sciences Ben'Msik-Bd Driss Elharti, BP 79, 55, Sidi Othman, Casablanca, Morocco; Département de biologie moléculaire, centre spécialisé des analyses médicale…
Zitieren
APA
Marchoudi, N., Amrani Hassani Joutei, H., Jouali, F., Fekkak, J., & Rhaissi, H. (2013). Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer. Pathologie Biologie, 61(6), 273-276. https://doi.org/10.1016/j.patbio.2013.05.004
Vancouver
Marchoudi N, Amrani Hassani Joutei H, Jouali F, Fekkak J, Rhaissi H. Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer. Pathologie Biologie. 2013;61(6):273-276. doi:10.1016/j.patbio.2013.05.004
BibTeX
@article{Marchoudi2013,
author = {Marchoudi, N and Amrani Hassani Joutei, H and Jouali, F and Fekkak, J and Rhaissi, H},
title = {Distribution of KRAS and BRAF mutations in Moroccan patients with advanced colorectal cancer},
journal = {Pathologie Biologie},
year = {2013},
volume = {61},
number = {6},
pages = {273--276},
doi = {10.1016/j.patbio.2013.05.004}
}
EUVIMED